Position in NKTR
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$73,091
-$2,672 QoQ
Shares Held
1,047
-0.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#197
of 239 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. NKTR ranks #35 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
3,962,177 | $344,511,290 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,389 | $2,676,877 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
86,557 | $2,668,552 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,063 | $662,823 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
1,699 | $631,467 | |
| 6 | ARGX |
Argenx SE
|
640 | $593,772 | |
| 7 | INCY |
Incyte Corp
|
4,961 | $562,378 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
13,833 | $539,625 |
All Filings in NKTR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,091 | 1,047 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $75,763 | 1,053 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $44,520 | 1,053 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $59,915 | 1,053 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $27,209 | 1,053 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $10,757 | 15,820 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $14,712 | 15,820 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $20,566 | 15,820 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $19,616 | 15,820 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $14,712 | 15,820 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $8,859 | 15,820 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $9,492 | 15,820 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $9,175 | 15,820 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $11,074 | 15,820 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $37,997 | 16,813 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $57,331 | 17,916 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $67,176 | 17,678 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $91,322 | 16,943 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $236,735 | 17,523 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $308,427 | 17,173 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $288,219 | 16,796 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $336,800 | 16,840 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $285,294 | 16,782 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $285,132 | 17,187 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $369,517 | 15,955 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $285,600 | 16,000 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||